Skip to Content

Join the 'Hepatocellular Carcinoma' group to help and get support from people like you.

Hepatocellular Carcinoma News

Related terms: Malignant Hepatoma, HCC

Bristol-Myers Squibb’s Opdivo (nivolumab) Now the First and Only FDA-Approved PD-1 Inhibitor to Offer Every Four-Week Dosing

Posted 14 Mar 2018 by Drugs.com

PRINCETON, N.J.--(BUSINESS WIRE) March 6, 2018 --Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) updating the Opdivo (nivolumab) dosing schedule to include 480 mg infused every four weeks (Q4W) for a majority of approved indications.1 This approval will provide health care ...

Liver Fluke Parasite May Threaten Lives of Hundreds of Vietnam War Veterans

Posted 22 Nov 2017 by Drugs.com

A tropical parasite may be slowly killing hundreds of U.S. veterans of the Vietnam War. Early this year, the Department of Veterans Affairs commissioned a small pilot study to investigate the link between liver flukes ingested through raw or undercooked fish and a rare bile duct cancer called cholangiocarcinoma, the Associated Press reported. Symptoms can take decades to appear and by the time ...

Lack of Awareness May Spur Spread of Hep C

Posted 1 Nov 2017 by Drugs.com

WEDNESDAY, Nov. 1, 2017 – Only about half of people in the United States with hepatitis C know they have the curable disease, new data shows. That lack of awareness contributes to increasing rates of hepatitis C infection and means the country is unlikely to meet its own or World Health Organization target dates for eliminating the disease, researchers said. Hepatitis C can cause liver disease, ...

Can Aspirin Stop Liver Cancer in Hepatitis B Patients?

Posted 20 Oct 2017 by Drugs.com

FRIDAY, Oct. 20, 2017 – Daily aspirin may reduce the risk of liver cancer for people with hepatitis B infection, a new study suggests. Hepatitis B virus attacks the liver and can cause cirrhosis and liver cancer. Previous research suggests daily low-dose aspirin therapy may prevent cancer, but there is little clinical evidence on whether regular aspirin use can prevent liver cancer in people ...

Mexican-Americans at Higher Risk for Liver Cancer

Posted 26 Sep 2017 by Drugs.com

MONDAY, Sept. 25, 2017 – Mexican-Americans have more risk factors for liver cancer than residents of Mexico do, a new study finds. Researchers compared data on almost 9,500 Mexicans living in Mexico; just over 2,300 U.S.-born Mexican-Americans living in the United States; and close to 2,000 Mexican-Americans who were born in Mexico and now live in the United States. Mexican-Americans were more ...

Bristol-Myers Squibb’s Opdivo (nivolumab) Receives FDA Approval for the Treatment of Hepatocellular Carcinoma Patients Previously Treated with Sorafenib

Posted 26 Sep 2017 by Drugs.com

PRINCETON, N.J.--(BUSINESS WIRE) September 22, 2017 --Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has approved Opdivo (nivolumab) injection for intravenous use for the treatment of patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib. Approval for this indication has been granted under accelerated ...

Stivarga Approved for Liver Cancer

Posted 28 Apr 2017 by Drugs.com

THURSDAY, April 27, 2017 – U.S. Food and Drug Administration approval of the anti-cancer drug Stivarga (regorafenib) has been expanded to include liver cancer, the agency said Thursday in a news release. Stivarga, among a class of drugs called kinase inhibitors, is designed to block enzymes that foster cancer growth. It's the first drug approved to treat liver cancer in nearly a decade, the FDA ...

FDA Expands Approved Use of Stivarga (regorafenib) to Treat Hepatocellular Carcinoma

Posted 28 Apr 2017 by Drugs.com

April 27, 2017 – The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafinib) to include treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who have been previously treated with the drug sorafenib. This is the first FDA-approved treatment for a liver cancer in almost a decade. “Limited treatment options are available for patients with l ...

Cancer Isn't 'One Size Fits All' for Hispanics

Posted 21 Feb 2017 by Drugs.com

TUESDAY, Feb. 21, 2017 – Cancer death rates can vary widely between different Hispanic ethnic groups in the United States, a new study finds. "Hispanic populations are all different, reflecting their country of origin, cultural experiences and socioeconomic status," said study author Dr. Paulo Pinheiro, an associate professor of epidemiology at the University of Nevada, Las Vegas. "If we can ...

More Evidence Linking Obesity to Liver Cancer

Posted 14 Oct 2016 by Drugs.com

FRIDAY, Oct. 14, 2016 – Having a large waistline, a high body mass index (BMI) and type 2 diabetes, may raise your risk for liver cancer, a new study suggests. "We found that each of these three factors was associated, robustly, with liver cancer risk," said study co-author Peter Campbell. He's strategic director of digestive system cancer research at the American Cancer Society. Liver cancer ...

Gene Variant May Explain Higher Rates of Some Cancers in Black People

Posted 31 Mar 2016 by Drugs.com

THURSDAY, March 31, 2016 – A single gene variant may explain why black Americans with common cancers have shorter survival times and higher death rates than other races, a new study suggests. While some researchers have examined possible socioeconomic factors to explain these differences, others have focused on genetics. "We may finally have a truly genetic explanation for why African-Americans ...

Screening Inmates for Hepatitis C Benefits General Community: Study

Posted 23 Nov 2015 by Drugs.com

MONDAY, Nov. 23, 2015 – A prison-based hepatitis C screening and treatment program could benefit the broader community, researchers suggest. Besides reducing the spread of hepatitis C after prisoners are released, "universal [hepatitis C] testing and treatment in prisons would reduce outcomes of advanced [hepatitis C] such as liver cancer, end-stage liver disease and death among prisoners," said ...

3 Drinks Per Day May Raise Liver Cancer Risk, But Coffee Lowers It

Posted 26 Mar 2015 by Drugs.com

THURSDAY, March 26, 2015 – People who have three or more alcoholic drinks per day could be raising their odds for liver cancer, according to a report from a panel of experts. But there was good news for java lovers: The report, from the World Cancer Research Fund International, found "strong evidence" that drinking coffee might actually lower a person's odds for liver cancer. In drawing together ...

Aspirin May Reduce Risk of Liver Cancer, Death From Liver Disease

Posted 28 Nov 2012 by Drugs.com

WEDNESDAY, Nov. 28 – Aspirin use seems to be associated with a decreased risk of liver cancer and death from chronic liver disease, according to a large new study. This new study included more than 300,000 people aged 50 to 71, who reported their aspirin and nonsteroidal anti-inflammatory drug (NSAID) use and were followed for 10 to 12 years. During that time, more than 400 participants died ...

Childhood Obesity May Raise Odds of Adult Liver Cancer

Posted 20 Apr 2012 by Drugs.com

FRIDAY, April 20 – Adults who were obese as children are at increased risk for liver cancer, a new study suggests. Researchers looked at the birth weight and body-mass index (a measurement of body fat based on height and weight commonly called BMI) of more than 165,000 men and 160,000 women in Denmark born between 1930 and 1989. Of those participants, 252 developed hepatocellular carcinoma, the ...

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Hepatic Tumor

Related Drug Support Groups

Opdivo, Nexavar, nivolumab, Stivarga, sorafenib, regorafenib